Dr. Lal Pathlabs Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Consistent revenue growth over the last four quarters indicates strong demand in the healthcare sector.
Improvement in profit margins suggests enhanced operational efficiency and cost management strategies.
Strong cash flow generation supports potential future investments and shareholder returns.

NEGATIVES

Rising competition in the diagnostics industry could pressure market share and profit margins.
Fluctuations in raw material costs may impact profitability if not managed effectively.
Regulatory challenges could pose risks to operational continuity and expansion plans.

Field	Jun 23	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25	Sep 25
Revenue	541	601.30	538.90	545.40	601.90	660.20	596.70	602.60	669.80	730.60
Expenses	394.80	423.50	398.30	400.70	431.90	457.70	442.70	433.60	477.50	506.50
Operating Profit	146.20	177.80	140.60	144.70	170	202.50	154	169	192.30	224.10
Other Income	14.40	18.10	18.30	18.40	20.60	21.90	25.10	25.80	28.10	24.80
Interest	8	7.80	7	6.60	6	6	5.30	5	4.70	4.80
Depreciation	35.10	35.90	36	36.60	34.70	35.30	35.50	36.40	34.60	40.50
Profit Before Tax	117.50	152.20	115.90	119.90	149.90	183.10	138.30	153.40	181.10	203.60
Tax	33.90	41.50	33.70	34.10	42.10	52.30	40.20	-2.10	47.10	51.40
Net Profit	83.60	110.70	82.20	85.80	107.80	130.80	98.10	155.50	134	152.20
Eps in Rs	9.95	13.16	9.77	10.13	12.79	15.52	11.60	18.57	15.88	18.05